Norris Medicines Ltd.

BSE: NORRIS524414ISIN INE744C01029

Services
Trading & Distributors

Share price

₹14.67-0.06 (-0.41%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹20.06
52W low: ₹12.00
Off 52W high: -26.87%
1M return: -8.71%
3M return: +4.71%
6M return: +4.79%
1Y return: -11.63%
20D avg volume: 555
50 DMA: ₹15.86
200 DMA: ₹14.75

Key ratios Standalone

Market cap: ₹14.67 Cr
Current price: ₹14.67
52W high / low: ₹20.06 / ₹12.00
Face value: ₹10.00
P/E: —
P/B: -1.02
EPS (TTM): —
Book value / share: —
ROE: -0.29%
ROCE: 6.50%
Operating margin: -30.49%
Net margin: -42.92%
Debt / equity: -1.42
Net debt: ₹21.51 Cr
Interest cover: 0.44
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 113.6 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	0.93	1.41	3.27	—	1.46	2.72	1.11	1.27	0.72	—
	0.00	0.02	0.00	—	0.02	0.05	0.00	0.00	0.01	—
	0.93	1.43	3.27	—	1.48	2.77	1.11	1.27	0.74	—
	1.32	1.38	2.57	—	1.79	2.94	1.39	1.63	1.10	—
	0.57	0.75	0.07	—	1.04	1.45	1.07	0.18	0.55	—
	0.00	0.00	0.00	—	0.00	0.00	—	—	—	—
	0.30	0.33	0.48	—	0.41	0.51	0.26	0.29	0.34	—
	0.00	0.15	0.13	—	0.11	0.15	0.12	0.08	0.08	—
	0.11	0.12	0.12	—	0.12	0.14	0.13	0.13	0.13	—
	0.28	0.33	0.42	—	0.42	0.37	—	—	0.37	—
	-0.40	0.05	0.70	—	-0.31	-0.17	-0.28	-0.36	-0.37	—
	0.00	0.00	0.00	—	0.00	0.00	—	—	—	—
	-0.40	0.05	0.70	—	-0.31	-0.17	-0.28	-0.36	-0.37	—
	0.00	0.00	0.00	—	0.00	0.06	—	—	—	—
	-0.40	0.05	0.70	—	-0.31	-0.23	-0.28	-0.36	-0.37	—
	-0.80	0.05	0.70	—	-0.62	-0.23	-0.28	-0.36	-0.37	—
Key metrics
	-0.29	0.32	0.95	—	-0.08	0.12	-0.03	-0.15	-0.16	—
	-31.20%	22.70%	29.10%	—	-5.50%	4.40%	-2.70%	-11.80%	-22.20%	—
	-43.00%	3.50%	21.40%	—	-21.20%	-8.50%	-25.20%	-28.30%	-51.40%	—
	—	6.00%	—	—	—	-0.50%	—	—	—	—
	-36.30%	-48.20%	194.60%	—	102.80%	—	—	—	—	—
	-29.00%	121.70%	350.00%	—	16.20%	—	—	—	—	—

Metric	FY26	FY25	FY24
Income statement
	8.13	5.82	—
	0.05	0.06	—
	8.18	5.88	—
	8.46	7.06	—
	4.34	3.37	—
	0.00	0.00	—
	1.67	1.41	—
	0.50	0.44	—
	0.49	0.54	—
	1.49	1.22	—
	-0.28	-1.18	—
	0.00	0.00	—
	-0.28	-1.18	—
	0.00	0.06	—
	-0.28	-1.24	—
	-0.28	-1.24	—
Key metrics
	0.71	-0.20	—
	8.70%	-3.40%	—
	-3.40%	-21.30%	—
	6.50%	-20.20%	—
	39.70%	—	—
	77.40%	—	—
	0.57	0.34	—
	-2.07	-0.29	—
	-1.42	-1.45	—
	21.51	21.54	—
	113.6	157.4	—
Balance sheet
	12.89	13.81	—
	5.81	6.34	—
	0.02	0.04	—
	1.17	1.41	—
	3.98	4.13	—
	—	0.00	—
	4.79	5.27	—
	2.62	3.03	—
	9.53	10.15	—
	21.53	21.58	—
	3.02	3.05	—
	18.51	18.53	—
	-15.15	-14.87	—
Cash flow
	0.58	0.36	—
	-0.08	-0.58	—
	-0.52	-0.49	—
	0.01	-0.02	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 34.00%

Quarter	September 2026	June 2026
Promoter %	34.00%	34.00%

Holder	Type	Holding	Previous	Change
FAB METALS PRIVATE LIMITED	Public	41.99%	41.99%	0.00%
VIMAL D SHAH	Promoter	23.60%	23.60%	0.00%
NAVSARJAN INVESTMENT & TRADING PVT LTD	Promoter Group	10.00%	10.00%	0.00%
LKP SECURITIES LIMITED	Public	1.50%	1.50%	0.00%
DHIRENDRA KANTILAL SHAH HUF	Promoter	0.34%	0.34%	0.00%
NAVNIT JETHABHAI PATEL	Promoter	0.04%	0.04%	0.00%
MILIND L UPADHYAYA	Promoter	0.01%	0.01%	0.00%
NIMISH BHISHMA THAKORE	Promoter	0.01%	0.01%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Redington Limited	28,660	366.60	18.17	19.00%	+31.26% TTM	-17.17% TTM	+46.46%
MMTC Ltd.	8,025	53.50	17.94	21.60%	-19.71% TTM	+355.55% TTM	-20.53%
MSTC Limited	4,106	583.25	17.52	31.80%	+21.02% TTM	-44.88% TTM	+6.22%
CREATIVE NEWTECH LIMITED	2,094	1,394.20	25.97	26.40%	—	—	—
Pervasive Commodities Limited S	1,137	12.62	74.24	0.00%	+111.30% TTM	+197.12% TTM	—
BN AGROCHEM LIMITED	1,117	114.20	65.40	4.20%	+84.51% TTM	-60.97% TTM	-68.29%
RRP DEFENSE LIMITED S	802	584.75	-330.37	-8.00%	+39.37% TTM	-364.13% TTM	-35.71%
The Yamuna Syndicate Ltd	750	24,400.00	8.22	0.30%	+11.33% TTM	-16.43% TTM	-32.22%
Shiv Aum Steels Limited	741	545.00	—	—	—	—	—
Riddhi Siddhi Gluco Biols Ltd	636	670.90	-27.71	2.80%	-37.98% TTM	+38.40% TTM	+20.31%
State Trading Corporation of India	624	104.00	—	-16.70%	—	—	-21.92%
Arvaya Healthcare Limited S	569	118.45	-311.71	-2.10%	-47.37% TTM	-2,742.86% TTM	+148.22%
Oswal Agro Mills Ltd.	548	40.86	-15.96	1.50%	-99.98% TTM	-127.15% TTM	-46.29%
SMT ENGINEERING LIMITED	459	254.15	18.72	24.80%	+248.17% TTM	+377.43% TTM	+169.03%
Filtron Engineers Ltd. S	451	71.04	1,420.80	0.30%	-100.00% TTM	+363.64% TTM	+67.00%
Kothari Products Ltd.	364	61.00	18.72	1.60%	+7.57% TTM	+124.93% TTM	-32.00%
Balgopal Commercial limited	337	145.00	-62.76	-12.50%	-96.08% TTM	-231.62% TTM	-35.47%
PIPAN OILS LIMITED S	323	184.25	-118.11	-191.70%	—	-1,342.11% TTM	+35.19%
VEGA JEWELLERS LIMITED S	315	61.95	10.45	31.50%	+465.43% TTM	+873.55% TTM	+60.24%
Novalum Materials Limited S	307	46.74	274.94	7.70%	+290.48% TTM	+239.39% TTM	+36.63%
Sakuma Exports Ltd.	285	1.82	26.72	1.80%	-13.44% TTM	-0.93% TTM	-34.53%
Parshva Enterprises Limited	254	249.05	950.47	3.60%	+0.24% TTM	+8.33% TTM	+32.09%
Polo Queen Industrial and Fintech Limited	253	7.54	110.89	2.50%	-2.02% TTM	-15.56% TTM	-79.87%
Sicagen India Limited	225	56.94	8.91	7.40%	+29.43% TTM	+50.03% TTM	-9.42%
Chandrima Mercantiles limited S	218	6.55	-163.75	4.30%	-69.52% TTM	-134.73% TTM	-34.63%
Norris Medicines Ltd. S	15	14.67	—	6.50%	—	—	-11.63%

Filings & corporate actions

Recent announcements

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September, 202612 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Scrutinizer''s Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 202629 Sep 2026 · Company Update / General
Scrutinizer''s Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 202629 Sep 2026 · AGM/EGM / AGM
Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 202629 Sep 2026 · Company Update / General
Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September, 202629 Sep 2026 · AGM/EGM / AGM
Outcome of 35th Annual General Meeting of the Company held on Tuesday, 29th September, 202629 Sep 2026 · AGM/EGM / AGM
Intimation of Closure of Trading Window26 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper advertisement regarding the 35th Annual General Meeting of the Company.7 Sep 2026 · Company Update / Newspaper Publication
Annual Report of the Company for the Financial year 2025-26.4 Sep 2026 · Others / Reg. 34 (1) Annual Report
Notice of 35th Annual General Meeting of the Company for the Financial Year 2025-264 Sep 2026 · AGM/EGM / AGM
Intimation of Book Closure for 35th AGM of the Company4 Sep 2026 · Corp. Action / Book Closure
Outcome of the Board Meeting on Thursday, 03rd September, 2026 pursuant to Regulation 30 of the SEBI(LODR) Regulations, 20153 Sep 2026 · Others / Outcome without intimation
Appointment of Mr. Vimal Dhirendra Shah (DIN: 01506655) as a Managing Director (Promoter and Executive) of the Company for a term of 3 (Three) consecutive years effective from 1st September, ....14 Aug 2026 · Company Update / Change in Management
Financial Results for the Quarter ended June 30,202614 Aug 2026 · Result / Financial Results
Board Meeting held on August 14, 2026 for the quarter ended June 30, 2026.14 Aug 2026 · Board Meeting / Outcome of Board Meeting
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....8 Aug 2026 · Board Meeting / Board Meeting
Intimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July, 2026.30 Jul 2026 · Company Update / Change in Management
Outcome of Board Meeting held on Thursday, July 30, 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.30 Jul 2026 · Others / Outcome without intimation
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30 June, 2026.3 Jul 2026 · Company Update / General
Intimation for Closure of Trading Window24 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Appointment of Internal Auditor w.e.f 30.05.202630 May 2026 · Company Update / Change in Management
As per attachment.30 May 2026 · Result / Financial Results
As per attachment.30 May 2026 · Board Meeting / Outcome of Board Meeting
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve As per attachment.25 May 2026 · Board Meeting / Board Meeting
As per attachment.20 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
As per attachment.26 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
As per attachment.14 Feb 2026 · Result / Financial Results
As per attachment14 Feb 2026 · Board Meeting / Outcome of Board Meeting
As per attachment.13 Feb 2026 · Company Update / General
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve As per attachment.11 Feb 2026 · Board Meeting / Board Meeting
As per attachment.4 Feb 2026 · Company Update / Change in Management
As per attachment.12 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
As per attachment.26 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
As per attachment12 Dec 2025 · Company Update / Resignation of Director
As per attachment.12 Dec 2025 · Company Update / General
Intimation regarding Order passed by Hon''ble High Court in Criminal Appeal No. 89 of 2020.11 Dec 2025 · Company Update / Award of Order / Receipt of Order
As per attachment.14 Nov 2025 · Board Meeting / Outcome of Board Meeting
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve As per attachment8 Nov 2025 · Board Meeting / Board Meeting
As per attachments.14 Oct 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
As per attachment.29 Sep 2025 · AGM/EGM / AGM

Board meetings

14 Aug 2026 Board Meeting - Financial Results